Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Teva Pharmaceutical Industries Limited American Depositary Shares
(NY:
TEVA
)
16.94
+0.07 (+0.41%)
Official Closing Price
Updated: 7:00 PM EDT, May 16, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Teva Pharmaceutical Industries Limited American Depositary Shares
< Previous
1
2
...
10
11
12
13
14
15
16
17
18
...
27
28
Next >
Teva to Host Conference Call to Discuss First Quarter 2023 Financial Results at 8 a.m. ET on May 10, 2023
April 14, 2023
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Why Teva Pharmaceutical Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Friday's Mid-Day Session
April 14, 2023
Gainers SAI.TECH Global Corporation (NASDAQ: SAI) jumped 269% to $5.61 after gaining around 25% on Thursday.
Via
Benzinga
Boeing, Spirit AeroSystems And Other Big Stocks Moving Lower In Friday's Pre-Market Session
April 14, 2023
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
Complete Response Letter Received for AVT02 Biologics License Application
April 13, 2023
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Trillions In Biotech Stock Gains Trace Back To This Financier
April 13, 2023
Frank did not grow up as son of a Wall Street banker. He began as the consummate outsider.
Via
Investor's Business Daily
Teva to Present New Data on Once-Daily AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets at the 2023 American Academy of Neurology Annual Meeting
April 11, 2023
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Emergent BioSolutions Soars: Analyst Upgrades Stock With Near 100% Upside After FDA's Positive Move
April 10, 2023
Via
Benzinga
7 A-Rated Stocks to Buy for April 2023
April 07, 2023
Now that the first quarter's in the bank, here are seven A-rated stocks to buy for April to keep your portfolio in top-notch shape.
Via
InvestorPlace
The Byzantine Adderall Shortage Puts Teva And Others In The Hot Seat
April 05, 2023
Millions of people are scrambling to get their ADHD medication. Here's why.
Via
Investor's Business Daily
Stage Set For Generics As Biden Admin Asks Supreme Court To Hear Skinny Labels Case Between GSK, Teva
March 31, 2023
Via
Benzinga
Is Big Pharma Coming For Your Cannabis Business?
March 27, 2023
Cannabis stocks have struggled in the market in recent years as the industry push to gain ground on the regulatory front hasn't progressed as quickly as investors had hoped. Yet beverage companies...
Via
Benzinga
Teva’s Digital Health Collaboration with Rimidi Expands to Include Respiratory Monitoring Program Integration with a Large U.S. Health System
March 27, 2023
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
7 Strong Buy Stocks Under $10 to Snap Up Now
March 23, 2023
Markets are missing out on these seven strong buy stocks under $10, which trade at too good a value score for savvy investors to ignore.
Via
InvestorPlace
3 No-Brainer Stocks to Buy With $10 Right Now
March 22, 2023
You don't need a large pile of money to begin building wealth on Wall Street.
Via
The Motley Fool
Catalyst Pharma The No. 1 Biotech, Just Crushed 2023 Guidance Estimates
March 15, 2023
The guidance includes Catalyst's newest, and second, product.
Via
Investor's Business Daily
Teva Announces Early Tender Results of its Debt Tender Offer, Increases to Tender Caps and Election of Early Settlement
March 13, 2023
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
7 Core Stocks to Build a Solid Portfolio Around
March 13, 2023
You’ll enjoy your investing journey more if you know that you can rely on your core of stocks to buy to provide a solid foundation.
Via
InvestorPlace
Teva and Natco Announce Launch of additional strengths for the Generic Version of Revlimid® (lenalidomide capsules), in the U.S.
March 09, 2023
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
BRTX’s ThermoStem®: A New Weapon In The Fight Against Metabolic Syndrome
March 09, 2023
By Julian Richard, Benzinga
Via
TheNewswire.com
BRTX’s ThermoStem®: A New Weapon In The Fight Against Metabolic Syndrome
March 09, 2023
BRTX’s ThermoStem®: A New Weapon In The Fight Against Metabolic Syndrome
Via
News Direct
BRTX's ThermoStem®: A New Weapon In The Fight Against Metabolic Syndrome
March 08, 2023
Metabolism is the chemical process whereby the body produces energy from food. By breaking down carbohydrates and fats into sugars, the cells access fuel that can be used or stored via the liver or...
Via
Benzinga
Teva to Present at the Barclays Global Healthcare Conference
March 07, 2023
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Better Generics Pharmaceutical Stock: Teva or Viatris?
March 05, 2023
Both have plans to return to growth.
Via
The Motley Fool
Teva Announces Successful Upsize and Pricing of $2,490,000,000 (equivalent) Sustainability-Linked Senior Notes and the Increase of the Maximum Tender Amount of its Debt Tender Offer
March 01, 2023
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
7 Smart Stock Picks for Cautious Investors
February 28, 2023
As market volatility continues, consider playing it safe with these seven high-quality stocks for cautious investors.
Via
InvestorPlace
Teva Announces $2,250,000,000 Debt Tender Offers for Notes Due 2023-2026
February 27, 2023
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Teva Announces Launch of $2,060,000,000 (Equivalent) Offering of Sustainability-Linked Senior Notes
February 27, 2023
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Teva to Present New Data from CONNECT2 Study on its Digihaler® System at the American Academy of Allergy, Asthma and Immunology (AAAAI) 2023 Annual Meeting
February 24, 2023
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Teva Announces Publication of New Clinician Scale in Journal of Clinical Psychiatry to Assess the Impact of Tardive Dyskinesia on Patients’ Lives
February 23, 2023
From
Teva Pharmaceutical Industries Limited
Via
Business Wire
Walmart, Home Depot And 3 Stocks To Watch Heading Into Tuesday
February 21, 2023
With US futures trading lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
< Previous
1
2
...
10
11
12
13
14
15
16
17
18
...
27
28
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.